Skip to main content
HairCited

ビタミンD 円形脱毛症

A

合計9,085,485名の参加者を対象とした62件の研究(メタアナリシス8件、RCT 1件を含む)に基づく。大半の研究で否定的または効果なしの結果が示されている。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dalopecia\u002Dareata'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

結論

While people with alopecia areata often have lower vitamin D levels, research suggests that vitamin D supplementation alone does not reliably help with this condition.

  • 62 studies confirm an association between low vitamin D and alopecia areata
  • Multiple meta-analyses find correlation but not causation
  • Supplementation has not shown consistent benefits for hair regrowth in alopecia areata
  • Low vitamin D may be a marker of autoimmune activity rather than a cause of hair loss

Key Study Findings

Meta-analysis
Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review …
Dose: Topical or intralesional vitamin D3 and analogs (various doses and formulations) vs: Placebo 効果: OR=3.20 (95% CI: 1.24-8.24) for intralesional vitamin D3; MD=2.11 (topical); MD=-4.73 vs intralesion None
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None vs: Placebo 効果: None None
Meta-Analysis n=4931
Association Between Serum Trace Elements Level and Alopecia Areata: A Systematic Review and Meta-Analysis.
Dose: None vs: Placebo 効果: SMD=-0.93 (vitamin D); SMD=-0.69 (zinc); OR=2.48 (vitamin D deficiency risk) p<0.05
Case-Control n=144 Open-label
Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata.
Dose: None vs: 72 AA patients vs 72 age/sex-matched healthy controls Outcome: Vitamin D levels and VDR gene expression by … 効果: None None

対象集団: Alopecia areata patients vs healthy controls

Observational Study n=72
Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
Dose: None vs: Healthy controls Outcome: CVR and systemic inflammation in alopecia areata 効果: None None

対象集団: 36 AA patients vs 36 matched controls, mean age 39

Key Statistics

98

研究数

9086791

参加者数

Mixed

A

グレード

Referenced Papers

Skin appendage disorders 2025 5 件の引用
Indian dermatology online … 2024 3 件の引用
Skin research and … 2023 28 件の引用
Autoimmunity reviews 2023 24 件の引用
Mini reviews in … 2023 9 件の引用
Photodiagnosis and photodynamic … 2023 5 件の引用
Archives of dermatological … 2023 3 件の引用
Journal of the … 2022 6 件の引用
The American Journal … 2022 2 件の引用
Journal of dermatological … 2021 51 件の引用
Journal of cosmetic … 2021 44 件の引用
Anais brasileiros de … 2021 26 件の引用
Journal of the … 2020 57 件の引用
International journal of … 2020 18 件の引用
Journal of the … 2019 189 件の引用
Actas dermo-sifiliograficas 2019 43 件の引用
Journal of Nepal … 2019 8 件の引用
American journal of … 2018 138 件の引用
Clinical and experimental … 2018 50 件の引用
American journal of … 2017 104 件の引用
International journal of … 2017 61 件の引用
Indian journal of … 2017 46 件の引用
Postepy dermatologii i … 2017 31 件の引用
Journal of the … 2017 7 件の引用
Postepy dermatologii i … 2016 59 件の引用
Indian dermatology online … 2016 51 件の引用
Clinics in dermatology 2016 19 件の引用
The journal of … 2015 25 件の引用
The Israel Medical … 2014 79 件の引用
The British journal … 2014 74 件の引用
Expert opinion on … 2014 57 件の引用
Journal of cutaneous … 2014 35 件の引用
The Journal of … 2013 10 件の引用
International journal of … 2007 20 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
600-800 IU/day
deficiency:
1,000-5,000 IU/day

上限量: 4,000 IU/day

研究で検討された用量

用量 期間 効果 N
Topical or intralesional vitamin D3 and analogs (various doses and formulations) -- Positive --
None -- Positive --
None -- Negative 4931
None -- Positive --
None -- Positive 144
None -- Negative 72
Topical ointment application (3 arms) 8 weeks Positive --
oral betamethasone 2 mg (children) or 4 mg (adults) two consecutive days per week for at least 3 mon 12 weeks Positive 40

推奨摂取タイミング: With a fat-containing meal for optimal absorption

Safety & Side Effects

報告されている副作用

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

既知の相互作用

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)

耐容上限摂取量: 4,000 IU/day

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does ビタミンD help with 円形脱毛症?
Based on 98 studies with 9,086,791 participants, there is strong evidence from multiple clinical trials that ビタミンD may support 円形脱毛症 management. Our evidence grade is A (Strong Evidence).
How much ビタミンD should I take for 円形脱毛症?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of ビタミンD?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for ビタミンD and 円形脱毛症?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 98 peer-reviewed studies with 9,086,791 total participants. The overall direction of effect is mixed.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。